Wai Yuen Tong Medicine Holdings Limited (HKG:0897)
0.3300
0.00 (0.00%)
Jun 1, 2026, 4:08 PM HKT
HKG:0897 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 368 | 405 | 286 | 434 | 357 | 413 | |
Market Cap Growth | -6.61% | 41.75% | -34.11% | 21.42% | -13.43% | 19.64% |
Enterprise Value | 561 | 695 | 2,682 | 2,941 | 3,005 | 2,731 |
Last Close Price | 0.33 | 0.36 | 0.13 | 0.03 | 0.03 | 0.03 |
PE Ratio | - | 57.05 | - | - | - | - |
PS Ratio | 0.51 | 0.54 | 0.37 | 0.60 | 0.26 | 0.37 |
PB Ratio | 0.31 | 0.34 | 0.21 | 0.12 | 0.09 | 0.10 |
P/TBV Ratio | 0.31 | 0.34 | 0.21 | 0.19 | 0.14 | 0.16 |
P/FCF Ratio | 4.38 | 5.39 | 1.82 | 3.22 | 2.50 | 1.17 |
P/OCF Ratio | 3.50 | 3.96 | 1.49 | 2.58 | 2.11 | 1.00 |
EV/Sales Ratio | 0.78 | 0.93 | 3.42 | 4.06 | 2.16 | 2.46 |
EV/EBITDA Ratio | 15.37 | - | 28.97 | 49.34 | 23.01 | 37.49 |
EV/EBIT Ratio | - | - | 65.61 | 589.41 | 43.19 | 197.47 |
EV/FCF Ratio | 6.69 | 9.25 | 17.08 | 21.80 | 21.00 | 7.73 |
Debt / Equity Ratio | 0.28 | 0.37 | 0.40 | 0.48 | 0.46 | 0.45 |
Debt / EBITDA Ratio | 9.14 | 9.99 | 3.68 | 14.95 | 10.17 | 16.63 |
Debt / FCF Ratio | 3.90 | 5.79 | 3.57 | 13.08 | 12.61 | 5.01 |
Net Debt / Equity Ratio | 0.17 | 0.25 | 0.27 | 0.32 | 0.30 | 0.28 |
Net Debt / EBITDA Ratio | -10.14 | -21.59 | 3.98 | 20.07 | 8.99 | 15.33 |
Net Debt / FCF Ratio | 2.32 | 3.89 | 2.35 | 8.87 | 8.21 | 3.16 |
Asset Turnover | 0.42 | 0.39 | 0.17 | 0.10 | 0.18 | 0.14 |
Inventory Turnover | 1.41 | 1.35 | 0.40 | 0.22 | 0.41 | 0.32 |
Quick Ratio | 0.41 | 0.67 | 0.81 | 0.44 | 0.41 | 0.36 |
Current Ratio | 1.27 | 1.73 | 2.18 | 1.63 | 1.54 | 1.36 |
Return on Equity (ROE) | -1.16% | 0.55% | -0.29% | 0.19% | -2.22% | -11.36% |
Return on Assets (ROA) | -1.88% | -1.53% | 0.56% | 0.04% | 0.56% | 0.11% |
Return on Invested Capital (ROIC) | -3.78% | -2.91% | 1.23% | 0.10% | 1.36% | 0.27% |
Return on Capital Employed (ROCE) | -4.30% | -3.40% | 2.40% | 0.10% | 1.20% | 0.20% |
Earnings Yield | -3.76% | 1.75% | -5.37% | -4.73% | -30.49% | -91.13% |
FCF Yield | 22.81% | 18.56% | 54.96% | 31.10% | 40.06% | 85.57% |
Dividend Yield | - | - | 22.51% | - | - | - |
Payout Ratio | - | 2804.83% | - | - | - | - |
Buyback Yield / Dilution | 3.43% | 4.70% | 2.87% | 1.25% | - | - |
Total Shareholder Return | 3.43% | 4.70% | 25.38% | 1.25% | - | - |